Lexicon Pharmaceuticals, INC.: directors' dealings · United States · SEC (Form 4)

Explore the full insider trade history of Lexicon Pharmaceuticals, INC., a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Lexicon Pharmaceuticals, INC. has recorded 15 insider filings. Market capitalisation: €943.9m. The latest transaction was filed on 2 May 2022 (Levée d'options). Among the most active insiders: DEBBANE RAYMOND. All data is openly available.